Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0LT2Z
|
|||
| Former ID |
DIB005418
|
|||
| Drug Name |
Vaccimel
|
|||
| Synonyms |
Melanoma cell line vaccine (cancer), Centro de Investigaciones Oncologicas; Autologous dendritic cells + allogeneic melanoma cell lines vaccine, Centro de Investigaciones Oncologicas/ Universidad de Buenos Aires; Dendritic cells + apoptotic/necrotic allogeneic melanoma cell lines vaccine, Centro de Investigaciones Oncologicas/ Universidad de Buenos Aires; DC/Apo-Nec vaccine (melanoma), Centro de Investigaciones Oncologicas/ Universidad de Buenos Aires
Click to Show/Hide
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 1 | [1] | |
| Company |
Centro de Investigaciones Oncol gicas CIO-FUCA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A phase I study of an allogeneic cell vaccine (VACCIMEL) with GM-CSF in melanoma patients. J Immunother. 2006 Jul-Aug;29(4):444-54. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.